Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Kim Theilgaard-Mönch

DMSC, associate professor

Københavns Biocenter, Ole Maaløes Vej 5

2200 København N


Vis graf over relationer


- Acute myeloid leukemia. (AML).

- Hematology

Primære forskningsområder

- Mapping of clonal hierarchies in patients with acute myeloid leukemia (AML).

- Identification and therapeutic targeting of oncogenic signaling pathways in AML.


- Application of "omics" technologies to improve prediction of therapy response in patients with AML.

Aktuel forskning

The major focus of the laboratory´s translational research program is to compare cancer cells to their closest normal cellular counterpart using a variety of “omics” technologies in order to improve prognostication as well as identify novel targets such as for treatment of patients with acute myeloid leukemia (AML).

Mulige interessekonflikter


ID: 33285667